Will global tender for Covid-19 vaccines by states help?

About a dozen states have opted for floating global tenders to procure Covid-19 vaccines. Most of those states face vaccine scarcity and have halted or slowed down vaccination within the 18-44 age-group.

Messages are rolling out from the authorities saying {that a} delay in getting second dose of vaccine will not impact their immunity in opposition to Covid-19 that developed after the primary dose. Covid-19 survivors are being informed to attend longer to get their first dose. Their pure immunity is anticipated to maintain them secure for about six months the least.


Vaccination drive in India has gone off the script similar because the Covid-19 containment technique. When Covid-19 instances had been on the decline from October 2020 to February 2021, the authorities tasked with dealing with Covid-19 state of affairs within the nation didn’t ramp up well being infrastructure to the extent required to handle the anticipated second wave of the coronavirus pandemic.

The graded vaccination drive, as deliberate and launched in January this yr, was amended underneath rising public stress, intense political questioning and stern remarks from the judiciary. It was opened for all adults from May 1. Private sector was roped in, and the states got liberty to obtain their vaccine doses.

The Indian companies, nevertheless, reportedly continued to work as per the path of the central authorities in provide vaccines. High demand accentuated by the rising tide of second Covid-19 wave made availability of vaccines acutely insufficient. Production of vaccines didn’t improve in proportion to rising demand within the backdrop of surge in Covid-19 cases. There was not sufficient infrastructural preparation for ramping up the manufacturing.

Now, states are floating global tenders for procuring vaccines.


States can solely procure vaccines authorised by the medication regulator, the Drugs Controller General of India (DCGI). Only three Covid-19 vaccines have been authorised by the DCGI — Covishield, Covaxin and Sputnik V.

Of these, Covishield-maker Serum Institute of India (SII) is the most important vaccine producer and is predicated in India. Covaxin is an Indian vaccine being manufactured by the Bharat Biotech, an Indian firm.

Sputnik V is a Russian Covid-19 vaccine and its producer has a dedication to produce the doses to over 80 international locations. It is already working behind the schedule. Its India companion, the Dr Reddy’s Lab remains to be weeks away from supplying to Indian markets.


Other vaccines which might be anticipated to get a nod from the DCGI in coming weeks embrace Pfizer’s and Moderna’s. Both are going through constraints in assembly the contracts they’d signed with the international locations in Europe.

Recently, the European Union sued AstraZeneca, which developed Oxford University’s vaccine often called Covishield in India, over not honouring the vaccine provide contract. It is unlikely that AstraZeneca, which has a companion in India, will enter right into a contract with any of the states floating global tenders for Covid-19 vaccines.


Possibly, the one nation that may be keen to produce Covid-19 vaccines to India within the required doses is China. It has been reaching out to international locations, which discovered their Covid-19 vaccine provide obstructed as India imposed restriction on the export of Covishield by the SII. China has already tapped Bangladesh and Sri Lanka after they didn’t obtain their consignments of Covishield.

But there may be one other downside. India is unlikely to approve Chinese vaccine manufactured by state-owned firm, Sinopharm. The World Health Organisation (WHO) approved last week for emergency use. Its efficacy has been underneath query.

Seychelles, a small nation within the Indian Ocean, has highest vaccine protection on the planet. But it witnessed sharp spike in Covid-19 instances prompting the WHO to overview why coronavirus infections had been spreading so quick amongst absolutely vaccinated individuals.

Political scientist and creator Ian Bremmer in a publish on Twitter earlier this week mentioned Seychelles has larger per capita Covid-19 instances than India. Seychelles principally used Chinese vaccine made by Sinpharm to vaccinate its individuals.


The states floating global tenders for vaccines are unsure in regards to the arrival of the jabs. This seems extra like an act out of desperation or to pacify the general public sentiments because the transfer alerts that the respective state governments try their bid to obtain Covid-19 vaccines obtainable wherever on the planet.

India is the largest vaccine producer and that’s the reason the central authorities had taken it as a accountability to export Covid-19 vaccines when the second wave of the pandemic had not struck India so onerous. Over 6 crore doses had been exported earlier than restrictions had been imposed.

Chief ministers have written to Prime Minister Narendra Modi arguing for wider approval for vaccine manufacturing. Andhra Pradesh Chief Minister Jagan Mohan Reddy sought involvement of extra corporations in vaccine manufacturing.

ALSO READ: Sputnik V Covid-19 vaccine to be available in market from next week: NITI Aayog member VK Paul

Reddy mentioned the central authorities ought to direct Bharat Biotech to switch Covaxin manufacturing expertise to public sector corporations able to producing the jab. West Bengal Chief Minister Mamata Banerjee made the same pitch in her letter to PM Modi.

The vaccine provide scarcity, nevertheless, is more likely to finish not earlier than July when new services of the makers of authorised vaccines would begin rolling out vials. The Centre informed the Supreme Court on Wednesday that vaccine manufacturing was being augmented.

The central authorities mentioned the entire manufacturing was more likely to go upto 13 crore vaccine doses by July from present 8.5 crore a month. This contains all three vaccines authorised in India.

People might have to attend until July for smoother reserving of Covid-19 vaccination slot and inoculation of the jabs. States, in the meantime, might need to reprioritise vaccine beneficiaries with give attention to bringing vaccine wastage to zero.

ALSO READ: People who recovered from Covid should wait for 6 months before getting jab, says govt panel

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.